Public health and veterinary medicine 
The findings should make it possible to propose preventive measures aiming to maintain the efficacy of the antibiotics required to combat infectious diseases in human beings and animals.
In particular, they should make it possible to use antibiotics in more targeted and appropriate ways in the future.
The control of emergence and the spread of resistance in the hospital environment should contribute to shortening average lengths of hospitalisation.

Food technology
The findings will be of use to the food industry in general, by determining whether foodstuffs are indeed an important vehicle for the transfer of resistance to man.

Molecular biology research of prokaryotes
Findings will be of use in an international context, where this problem is currently being discussed. It may be possible to identify new resistance or transfer mechanisms.
The programme will boost the interest of Swiss research into the genetics and biology of prokaryotes.

Pharmaceutical industry
The pharmaceutical industry will profit from findings on resistance, notably in relation to biochemistry.

Economy
The long term economic repercussions of the findings are evident, with regard to health costs, food and farming technology, the pharmaceutical industry and diagnostics.

Law and society
The studies should make the population more aware of the problem of antibiotic resistance in general and prepare society for possible new regulations on the use of antimicrobial agents.